PTGX — Protagonist Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Protagonist Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	327	237	342	419	567
Net Total Accounts Receivable
Net Total Receivables	5.33	0.052	10.3	168	4.5
Prepaid Expenses
Total Current Assets	341	243	356	592	578
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.73	4.63	2.15	12.6	11.7
Long Term Investments
Other Long Term Assets
Total Assets	348	248	358	745	668
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	44	31.2	21.3	47.4	45.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	47.7	32.3	21.3	69.4	53.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	300	216	337	675	615
Total Liabilities & Shareholders' Equity	348	248	358	745	668
Total Common Shares Outstanding